Skip to Main Content

Meena S. Moran, MD

Professor of Therapeutic Radiology; Chief, Breast Radiation Oncology

Contact Information

Meena S. Moran, MD

Mailing Address

  • Therapeutic Radiology

    P. O. Box 208040

    New Haven, CT 06520-8040

    United States

Research Summary

Current research interests include identifying clinical, pathologic and molecular markers that are predictive of local-regional relapse after breast conserving surgery and radiation therapy.

Coauthors

Research Interests

Complementary Therapies; Breast; Pelvis; Quality Assurance, Health Care; Quality of Health Care; Radiotherapy; Radiotherapy, Adjuvant

Selected Publications

  • 85: The Use of Bolus in Postmastectomy Radiation Therapy for Breast Cancer: A Systematic ReviewDahn H, Boersma L, de Ruysscher D, Meattini I, Offersen B, Pignol J, Belkacemi Y, Benjamin D, Bese N, Coles C, Franco P, Ho A, Hol S, Jagsi R, Kirby A, Marrazzo L, Marta G, Moran M, Nichol A, Nissen H, Strnad V, Zissiadis Y, Aristei C, Poortman P, Kaidar-Person O. 85: The Use of Bolus in Postmastectomy Radiation Therapy for Breast Cancer: A Systematic Review Radiotherapy And Oncology 2021, 163: s38. DOI: 10.1016/s0167-8140(21)08963-5.
  • 54: International Expert Delphi Consensus Guidelines for the Use of Bolus in Post Mastectomy Radiation TherapyDahn H, Boersma L, de Ruysscher D, Meattini I, Offersen B, Pignol J, Aristei C, Benjamin D, Bese N, Coles C, Franco P, Ho A, Hol S, Jagsi R, Kirby A, Marrazzo L, Marta G, Moran M, Nichol A, Nissen H, Strnad V, Zissiadis Y, Poortmans P, Kaidar-Person O. 54: International Expert Delphi Consensus Guidelines for the Use of Bolus in Post Mastectomy Radiation Therapy Radiotherapy And Oncology 2021, 163: s26. DOI: 10.1016/s0167-8140(21)08932-5.
  • ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality MeasuresBleicher R, Moran M, Ruth K, Edge S, Dietz J, Wilke L, Stearns V, Kurtzman S, Klein J, Yao K. ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures Annals Of Surgical Oncology 2021, 28: 572-573. DOI: 10.1245/s10434-021-10535-8.
  • CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are IrradiatedPeters G, Gao S, Knowlton C, Zhang A, Evans S, Higgins S, Wilson L, Saltmarsh N, Picone M, Moran M. CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated Journal Of The National Comprehensive Cancer Network 2021, 19: clo21-025. DOI: 10.6004/jnccn.2020.7707.
  • Physician’s comfort level with observing ductal carcinoma in situ of the breast: a survey of breast specialists at accredited breast centers in the United StatesPoli E, Chang C, Bleicher R, Moran M, Dietz J, Sarantou T, Kurtzman S, Yao K. Physician’s comfort level with observing ductal carcinoma in situ of the breast: a survey of breast specialists at accredited breast centers in the United States Annals Of Breast Surgery 2021, 0: 0-0. DOI: 10.21037/abs-22-1.
  • Breast CancerKnowlton C, Moran M. Breast Cancer 2020 DOI: 10.1891/9780826155146.0019.
  • Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic FeaturesJagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Thomas T, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s7-s8. DOI: 10.1016/j.ijrobp.2019.06.392.
  • PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDBChowdhary M, Lee A, Gao S, Barry P, Diaz R, Bagadiya N, Park H, Yu J, Wilson L, Moran M, Higgins S, Knowlton C, Patel K. PV-0045 Is proton therapy a "pro" for breast cancer? A comparison of proton vs. non-proton RT using the NCDB Radiotherapy And Oncology 2019, 133: s15. DOI: 10.1016/s0167-8140(19)30465-7.
  • EP-1328: Impact of deep inspiration breath hold on heart and lung dose constraints in a large breast seriesLoganadane G, Kann B, Young M, Knowlton C, Higgins S, Belkacemi Y, Wilson L, Moran M. EP-1328: Impact of deep inspiration breath hold on heart and lung dose constraints in a large breast series Radiotherapy And Oncology 2018, 127: s727-s728. DOI: 10.1016/s0167-8140(18)31638-4.
  • EP-1321: Incidental radiation dose to the internal mammary chain in a large clinical breast seriesLoganadane G, Kann B, Young M, Knowlton C, Evans S, Higgins S, Belkacemi Y, Wilson L, Moran M. EP-1321: Incidental radiation dose to the internal mammary chain in a large clinical breast series Radiotherapy And Oncology 2018, 127: s724. DOI: 10.1016/s0167-8140(18)31631-1.
  • Patterns of Care and Outcomes of Patients With Breast Cancer Who Refuse Recommended TherapyJohnson S, An Y, Kelly J, Aneja S, Mougalian S, Young M, Moran M, Evans S. Patterns of Care and Outcomes of Patients With Breast Cancer Who Refuse Recommended Therapy International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e20-e21. DOI: 10.1016/j.ijrobp.2017.06.639.
  • The Impact of Standardized Treatment Planning Guidelines on Treatment Plan QualityKelly J, Park H, Carlson D, Moran M, Wilson L, Young M, Higgins S, Guay D, Arthur G, Simmons W, Winter S, Evans S. The Impact of Standardized Treatment Planning Guidelines on Treatment Plan Quality International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e556. DOI: 10.1016/j.ijrobp.2017.06.1936.
  • Radiation Oncology Considerations in the Management of Mutation Carriers with Breast CancerMoran M. Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer 2017, 151-170. DOI: 10.1007/978-3-319-59198-8_9.
  • Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic InstitutionsMoran M, Zhao Y, Ma S, Kirova Y, Fourquet A, Chen P, Hoffman K, Hunt K, Wong J, Halasz L, Freedman G, Prosnitz R, Yassa M, Nguyen D, Hijal T, Haffty B, Wai E, Truong P. Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s144. DOI: 10.1016/j.ijrobp.2016.06.349.
  • La Danse d'un Cygne (The Dance of a Swan)Moran M. La Danse d'un Cygne (The Dance of a Swan) International Journal Of Radiation Oncology • Biology • Physics 2016 DOI: 10.1016/j.ijrobp.2016.06.2451.
  • Recent Updates in the Management of Triple Negative Breast CancerSanft T, Moran M. Recent Updates in the Management of Triple Negative Breast Cancer Oncology & Hematology Review (US) 2016, 12: 36. DOI: 10.17925/ohr.2016.12.01.36.
  • Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation.Wobb J, Chen P, Shah C, Moran M, Shaitelman S, Vicini F, Mbah A, Lyden M, Beitsch P. Nomogram for predicting the risk of locoregional recurrence in patients treated with accelerated partial-breast irradiation. Journal Of Clinical Oncology 2014, 32: 59-59. DOI: 10.1200/jco.2014.32.26_suppl.59.
  • Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative PhenotypeGarg R, Housri N, Kongara S, Wu H, Schiff D, Moran M, Karantza V, Haffty B. Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative Phenotype International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s69-s70. DOI: 10.1016/j.ijrobp.2014.05.230.
  • Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiationRutter C, Qin L, Higgins S, Moran M, Evans S. Dosimetric and clinical predictors of the development of moist desquamation in breast cancer irradiation Journal Of Radiation Oncology 2013, 3: 147-152. DOI: 10.1007/s13566-013-0129-0.
  • Dosimetric and Clinical Predictors of the Development of Moist Desquamation in Breast Cancer IrradiationRutter C, Qin L, Higgins S, Moran M, Evans S. Dosimetric and Clinical Predictors of the Development of Moist Desquamation in Breast Cancer Irradiation International Journal Of Radiation Oncology • Biology • Physics 2013, 87: s210. DOI: 10.1016/j.ijrobp.2013.06.545.
  • Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast CancerJones T, Neboori H, Haffty B, Wu H, Yang Q, Moran M. Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast Cancer International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s141. DOI: 10.1016/j.ijrobp.2012.07.164.
  • Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated With Locoregional Recurrence in a Case-control Study of Women With 0-3 Positive Lymph Nodes After MastectomyKhan A, Milgrom S, Barnard N, Higgins S, Moran M, Kim S, Goyal S, Alfaraj F, Haffty B. Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated With Locoregional Recurrence in a Case-control Study of Women With 0-3 Positive Lymph Nodes After Mastectomy International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s141. DOI: 10.1016/j.ijrobp.2012.07.165.
  • DEAD box 1 (DDX1) Expression Predicts for Local Control and Overall Survival in Early-stage, Node-negative Breast Cancer Treated with Breast Conserving Surgery and Radiation TherapyTaunk N, Goyal S, Wu H, Moran M, Chen S, Haffty B. DEAD box 1 (DDX1) Expression Predicts for Local Control and Overall Survival in Early-stage, Node-negative Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s63-s64. DOI: 10.1016/j.ijrobp.2011.06.128.
  • The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and RadiotherapyNeboori H, Wu H, Schiff D, Goyal S, Moran M, Yang J, Hirshfield K, Haffty B. The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and Radiotherapy International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s62-s63. DOI: 10.1016/j.ijrobp.2011.06.126.
  • Interferon-induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT)Danish H, Goyal S, Taunk N, Wu H, Moran M, Haffty B. Interferon-induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT) International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s214. DOI: 10.1016/j.ijrobp.2011.06.394.
  • Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings?Bai H, Lannin D, Higgins S, Motwani S, Hafty B, Goyal S, Wilson L, Evans S, Moran M. Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings? International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s245. DOI: 10.1016/j.ijrobp.2011.06.1716.
  • A prospective, multicenter trial of complementary and alternative medicine (CAM) utilization by patients undergoing definitive breast radiotherapy.Moran M, Yang J, Ma S, Gaudreau B, Higgins S, Weidhaas J, Wilson L, Peschel R, Fass D, Rockwell S. A prospective, multicenter trial of complementary and alternative medicine (CAM) utilization by patients undergoing definitive breast radiotherapy. Journal Of Clinical Oncology 2011, 29: 241-241. DOI: 10.1200/jco.2011.29.27_suppl.241.
  • SU‐E‐T‐485: Clinical Evaluation of Inverse Planning Models and IMRT Delivery Systems in the Framework of AAPM TG‐119 ProtocolAhmad M, Liu W, Lund M, Moran M, Richards P, Wu D, Chen Z, Deng J, Nath R. SU‐E‐T‐485: Clinical Evaluation of Inverse Planning Models and IMRT Delivery Systems in the Framework of AAPM TG‐119 Protocol Medical Physics 2011, 38: 3600-3600. DOI: 10.1118/1.3612438.
  • Breast Conservation Therapy and BRCA Status Do Not Predict for Poor Outcomes in Young Women with Early-stage Breast CancerPatel A, Goyal S, Moran M, Choi D, Haffty B. Breast Conservation Therapy and BRCA Status Do Not Predict for Poor Outcomes in Young Women with Early-stage Breast Cancer International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s213. DOI: 10.1016/j.ijrobp.2010.07.513.
  • Racial Disparities in Treatment Outcomes for African American Women with Ductal Carcinoma In Situ Receiving Whole Breast Irradiation following Breast Conserving SurgeryNelson C, Goyal S, Moran M, Motwani S, Haffty B. Racial Disparities in Treatment Outcomes for African American Women with Ductal Carcinoma In Situ Receiving Whole Breast Irradiation following Breast Conserving Surgery International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s222. DOI: 10.1016/j.ijrobp.2010.07.533.
  • Extent of Axillary Dissection Predicts Survival in pN0 Early Stage Breast CancerParikh R, Khan A, Goyal S, Ahlawat S, Moran M, Haffty B. Extent of Axillary Dissection Predicts Survival in pN0 Early Stage Breast Cancer International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s228-s229. DOI: 10.1016/j.ijrobp.2010.07.548.
  • Riluzole Increases Ionizing Radiation Related Cellular Toxicity in Metabotropic Glutamate Receptor 1 Positive Human Breast Cancer CellsAhlawat S, Khan A, Goyal S, Schiff D, Wu H, Moran M, Haffty B. Riluzole Increases Ionizing Radiation Related Cellular Toxicity in Metabotropic Glutamate Receptor 1 Positive Human Breast Cancer Cells International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s160. DOI: 10.1016/j.ijrobp.2010.07.394.
  • Tamoxifen Confers a Limited Benefit in Older Women with Early Stage Breast CancerKhan A, Parikh R, Goyal S, Moran M, Haffty B. Tamoxifen Confers a Limited Benefit in Older Women with Early Stage Breast Cancer International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s212-s213. DOI: 10.1016/j.ijrobp.2010.07.512.
  • 7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapyPierce L, Phillips K, Griffith K, Buys S, Gaffney D, Moran M, Haffty B, Ben-David M, Garber J, Merajver S, Balmaña J, Meirovitz A, Domchek S. 7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy European Journal Of Cancer Supplements 2010, 8: 55. DOI: 10.1016/s1359-6349(10)70034-3.
  • Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy.Pierce L, Phillips K, Griffith K, Buys S, Gaffney D, Moran M, Haffty B, Ben-David M, Garber J, Merajver S, Balmanya J, Meirovitz A, Domchek S. Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy. Cancer Research 2009, 69: 959-959. DOI: 10.1158/0008-5472.sabcs-09-959.
  • Prognostic Value of P53 Expression in Patients Treated with Breast Conserving TherapyRewari A, Goyal S, Taunk N, Wu H, Moran M, Haffty B. Prognostic Value of P53 Expression in Patients Treated with Breast Conserving Therapy International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s195. DOI: 10.1016/j.ijrobp.2009.07.452.
  • Evaluation of Single Nucleotide Polymorphisms (SNP) in the P53 Binding Protein Gene (TP53BP1), in Breast Cancer Patients Treated with Breast Conserving Surgery and Whole-breast Irradiation (BCS+RT)Haffty B, Goyal S, Green C, Schiff D, Yang Q, Moran M, Kulkarni D, Ganesan S, Hirshfield K. Evaluation of Single Nucleotide Polymorphisms (SNP) in the P53 Binding Protein Gene (TP53BP1), in Breast Cancer Patients Treated with Breast Conserving Surgery and Whole-breast Irradiation (BCS+RT) International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s6. DOI: 10.1016/j.ijrobp.2009.07.040.
  • Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-stage Breast Cancer Patients Treated with Breast Conservation TherapyMoran M, Yang Q, Goyal S, Haffty B. Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-stage Breast Cancer Patients Treated with Breast Conservation Therapy International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s7-s8. DOI: 10.1016/j.ijrobp.2009.07.043.
  • Mucinous (Colloid) Carcinoma of the Breast: Clinicopathologic Features & Long-term Outcomes of Women Treated with Breast-conserving TherapyParikh R, Taunk N, Moran M, Haffty B. Mucinous (Colloid) Carcinoma of the Breast: Clinicopathologic Features & Long-term Outcomes of Women Treated with Breast-conserving Therapy International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s200-s201. DOI: 10.1016/j.ijrobp.2009.07.464.
  • Low-risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery and Radiotherapy: Comparison with Intergroup Study E5194Motwani S, Galper S, Goyal S, Moran M, Haffty B. Low-risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery and Radiotherapy: Comparison with Intergroup Study E5194 International Journal Of Radiation Oncology • Biology • Physics 2009, 75: s53-s54. DOI: 10.1016/j.ijrobp.2009.07.143.
  • Ductal Carcinoma In Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary EvaluationParikh R, Haffty B, Moran M. Ductal Carcinoma In Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s150-s151. DOI: 10.1016/j.ijrobp.2008.06.481.
  • Prognostic Implications of Mammographically Occult, Early Stage Breast Cancer Patients Treated with Breast Conservation TherapyYang T, Yang Q, Haffty B, Moran M. Prognostic Implications of Mammographically Occult, Early Stage Breast Cancer Patients Treated with Breast Conservation Therapy International Journal Of Radiation Oncology • Biology • Physics 2008, 72: s92. DOI: 10.1016/j.ijrobp.2008.06.976.
  • Using Nodal Ratios to Predict the Risk of In-Field Regional Recurrences in Patients Treated With Breast Conservation Therapy in Patients With 4 or More Positive Lymph NodesCastrucci W, Haffty B, Moran M. Using Nodal Ratios to Predict the Risk of In-Field Regional Recurrences in Patients Treated With Breast Conservation Therapy in Patients With 4 or More Positive Lymph Nodes International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s212. DOI: 10.1016/j.ijrobp.2007.07.1179.
  • Differences between African American (AA) and Caucasian (C) Patients Treated With Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast CancerMoran M, Harris L, Haffty B. Differences between African American (AA) and Caucasian (C) Patients Treated With Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast Cancer International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s4-s5. DOI: 10.1016/j.ijrobp.2007.07.010.
  • Estrogen-Dependent Prognostic Significance of COX-2 in Early Stage Invasive Breast CancerHaffty B, Moran M, Yang Q, Tan A, Reiss M. Estrogen-Dependent Prognostic Significance of COX-2 in Early Stage Invasive Breast Cancer International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s27. DOI: 10.1016/j.ijrobp.2007.07.048.
  • Clinical Utility of the Modified Segmental Boost Technique (MSBT)Higgins S, Castrucci W, Lund M, Ahmad M, Mason C, Roy P, Mickenzie A, Mani S, Moran M. Clinical Utility of the Modified Segmental Boost Technique (MSBT) International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s404-s405. DOI: 10.1016/j.ijrobp.2007.07.1535.
  • SU‐FF‐T‐106: Clinical Implementation of Varian Enhanced Dynamic Wedges Into the Pinnacle Treatment Planning System: Monte Carlo Dosimetry and Patient‐Specific Quality Assurance TechniquesAhmad M, Deng J, Chen Z, Lund M, Kimmett J, Moran M, Nath R. SU‐FF‐T‐106: Clinical Implementation of Varian Enhanced Dynamic Wedges Into the Pinnacle Treatment Planning System: Monte Carlo Dosimetry and Patient‐Specific Quality Assurance Techniques Medical Physics 2007, 34: 2425-2425. DOI: 10.1118/1.2760762.
  • SU‐FF‐T‐361: Planning Study of Intensity‐Modulated and 3D Conformal Radiotherapy of Whole Pelvis Including Inguinal Lymphatics: Radiobiological Considerations for Designing New Fractionation SchemesAhmad M, Song H, Lund M, Niemierko A, Moran M, Weidhaas J, Higgins S, Chen Z, Deng J, Nath R. SU‐FF‐T‐361: Planning Study of Intensity‐Modulated and 3D Conformal Radiotherapy of Whole Pelvis Including Inguinal Lymphatics: Radiobiological Considerations for Designing New Fractionation Schemes Medical Physics 2006, 33: 2129-2129. DOI: 10.1118/1.2241281.
  • Imrt of whole pelvis and inguinal nodes: Evaluation of dose distributions produced by an inverse treatment planning systemAhmad M, Song H, Moran M, Lund M, Chen Z, Deng J, Haffty B, Nath R. Imrt of whole pelvis and inguinal nodes: Evaluation of dose distributions produced by an inverse treatment planning system International Journal Of Radiation Oncology • Biology • Physics 2004, 60: s484-s485. DOI: 10.1016/j.ijrobp.2004.07.410.
  • 1. Effects of Breast Conserving Therapy on Lactation after PregnancyMoran M. 1. Effects of Breast Conserving Therapy on Lactation after Pregnancy The Cancer Journal 2003, 9: 485. DOI: 10.1097/00130404-200311000-00009.
  • Improved treatment of the pelvis and inguinal nodes using the modified segmental boost technique: dosimetric evaluationMoran M, Lund M, Lund M, Ahmad M, Ahmad M, Gignac J, Gignac J, Breneman M, Breneman M, Dustin J, Dustin J, Trumpore S, Trumpore S, Haffty B, Nath R. Improved treatment of the pelvis and inguinal nodes using the modified segmental boost technique: dosimetric evaluation International Journal Of Radiation Oncology • Biology • Physics 2002, 54: 344-345. DOI: 10.1016/s0360-3016(02)03649-0.
  • Conservatively Treated Breast Cancer: Outcome by Histologic SubtypeHaffty B, Perrotta P, Ward B, Moran M, Beinfield M, McKhann C, Fischer D, Carter D. Conservatively Treated Breast Cancer: Outcome by Histologic Subtype The Breast Journal 1997, 3: 7-14. DOI: 10.1111/j.1524-4741.1997.tb00134.x.

Clinical Trials